Objective To revise and expand the 1992 edition of the clinical practice guidelines for the
management of diabetes in Canada incorporating recent advances in diagnosis and outpatient …

This lively history of Yale traces the development of the college from its founding in 1701 by
a small group of Puritan clergymen intent on preserving the purity of the faith in Connecticut, …

… Yale reports the following: research support from AstraZeneca, Boehringer Ingelheim, Eli
Lilly, Janssen, Medtronic, Merck, and Sanofi; served on advisory panels for Abbott, AstraZeneca…

The results of the Diabetes Control and Complications Trial (DCCT) and UK Prospective
Diabetes Study trials in type 1 and type 2 diabetes, respectively, have proved the importance of …

Aims Canagliflozin is a sodium glucose co‐transporter 2 inhibitor in development for
treatment of type 2 diabetes mellitus ( T2DM ). This study evaluated the efficacy and safety of …

This indicated that the primary site of action of adminis-tered pV was the endosomal IRK-associated
PTP (6). pVs have been shown to be specific in their action in that they are potent …

Aim This study evaluated the efficacy and safety of canagliflozin, a sodium glucose co‐transporter
2 inhibitor, in patients with type 2 diabetes mellitus (T2DM) and within a subset of …

Address for correspondence: Lawrence A. Leiter St. Michael's Hospital 61 Queen Street
East, Room 6121 Toronto, Ontario M5C 2T2 Canada Telephone:(416) 867-7441 Fax:(416) …

Aims Insulin is generally withheld until people with Type 2 diabetes are unresponsive to
other therapies. However, its potential advantages suggest that it could be added earlier to …

Objective: To assess the effects of a computer-based patient record system on human cognition.
Computer-based patient record systems can be considered “cognitive artifacts,” which …